XENE Stock Analysis: Buy, Sell, or Hold?
XENE - Xenon Pharmaceuticals Inc
$59.75
-0.65 (-1.08%)
▼
5d:
-0.4%
30d:
-7.44%
90d:
+15.5%
HOLD
MODERATE Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When XENE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XENE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XENE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XENE is currently trading at $59.75, which is considered oversold relative to its 30-day fair value range of $60.59 to $64.11.
Technical Outlook: Technically, XENE is in a uptrend. The price is currently testing key support at $59.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $81.30 (+36.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XENE is in a uptrend. The price is currently testing key support at $59.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $81.30 (+36.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$60.59 -
$64.11
Company Quality Score
56/100
(HOLD)
Options IV Signal
5th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
86.2%
Protect Your Profits
Holding XENE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 5th percentile)
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.1% below Wall St target ($81.30)
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$60.59 -
$64.11
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$4.28
(7.2%)
Support & Resistance Levels
Support Level
$59.22
Resistance Level
$64.81
Current Trend
Uptrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.28
Wall Street Target
$81.30
(+36.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 05, 2026 6:07 AM ET
Data refreshes hourly during market hours. Next update: 7:07 AM
Data refreshes hourly during market hours. Next update: 7:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XENE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Andrea Difabio
SELL
1342 shares
2026-03-13
Christopher John Kenney
SELL
1410 shares
2026-03-13
Ian Mortimer
SELL
7308 shares
2026-03-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 46 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1176 | 44 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$287 | 64 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 27 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 35 SELL |
Advanced XENE Option Strategies
Professional options setups generated by AI based on today's XENE price and gamma walls.